Michael I. Bennett

TL;DR: A number of key areas are addressed: communication, starting strong opioids, first-line treatment options, titrating the dose, maintenance phase and what to do when oral opioids are not suitable, management of breakthrough pain, and management of side effects (constipation, nausea and drowsiness).

TL;DR: In this article , the authors identify community pharmacists' and pharmaceutical wholesalers'/distributors' views on supply chain processes and challenges in providing access to medicines during the last year of life, to characterise supply in this UK context.

TL;DR: In this paper, the authors explored the perspectives and experiences of members of primary health care teams involved in the care of patients with advanced cancer during the last year of life. And they identified distinct differences in the drivers and barriers of community advanced cancer care coordination, which relate to identification and management, and access to effective pain management.

TL;DR: No clear evidence demonstrating superiority of regular dosing of opioids compared with as needed dosing in persistent cancer pain is found andregular dosing was associated with significantly higher total opioid doses.

TL;DR: The role of the hospice pharmacist is not well described as discussed by the authors, despite surveys of provision, despite the fact that pharmacists are important members of multidisciplinary teams, the role of a pharmacist in a multi-disciplinary team is not described well.